tirzepatide dedham How the weight loss drug is also helping heart failure patients Maintenance therapy on semaglutide or

While gastrointestinal side effects like nausea and diarrhea are common with this GLP-1 receptor agonist, colitisinflammation of the colonhas not been established as a recognized adverse effect in FDA labeling or major clinical trials

For someone on tirzepatide who is adjusting their diet and increasing physical activity, these effects could meaningfully improve body composition outcomes

In clinical trials, it has demonstrated superior efficacy, with participants on the highest dose achieving an average weight loss of approximately 21% over 72 weeks

WhatsApp For Advice +91 70263 13502

Is a GLP-1 medication right for me